SkinHealth Systems Announces Reverse Stock Split
The split will not change percentage ownership, except for fractional shares, which will be paid in cash rather than issued.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SkinHealth Systems (Nasdaq: SKIN) will implement a 1-for-20 reverse stock split of its Class A common stock on October 14, 2026.
The split takes effect at 12:00 a.m. ET, with split-adjusted trading expected at market open that day. The company intends the split to help regain compliance with Nasdaq’s $1.00 minimum bid price requirement. Based on shares outstanding as of October 7, 2026, the outstanding count is expected to fall from approximately 130.3 million to 6.5 million. Authorized shares will remain unchanged. The conversion rate of its 7.95% Convertible Senior Secured Notes due 2028 will be adjusted proportionately.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Nasdaq’s $1.00 minimum bid price requirement prompts the reverse split intended to regain continued-listing compliance.
News Explained
The board-approved 1-for-20 split reduces each Class A holder’s share count but, the company says, leaves percentage ownership unchanged except for fractional shares, for which cash will be paid instead of issuing a partial share.
Details
Market Reaction – SKIN
On Oct 9, the day this news came out, the latest delayed price for SKIN is 1.95% above the previous close. Our momentum scanner has recorded 4 alerts for this stock so far that day. The latest delayed price is $0.58. Relative volume is exceptionally heavy at 15.1x the average.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Reverse split ratio
- 1-for-20
- Board-approved ratio for the Class A common stock
- Effective date
- October 14, 2026
- Reverse stock split effective at 12:00 a.m. ET
- Nasdaq minimum bid requirement
- $1.00
- Continued-listing requirement cited as the split's intended compliance objective
Key Terms
reverse stock split financial
cusip financial
par value financial
convertible senior secured notes financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Shares expected to begin trading on split-adjusted basis on October 14, 2026
LONG BEACH, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN) (the “Company”), home to flagship brand Hydrafacial™, today announced that its Board of Directors has approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s Class A common stock, par value
At the Company’s Special Meeting of Stockholders held on September 22, 2026, stockholders approved a proposal authorizing a Reverse Stock Split with the exact ratio to be determined by the Board of Directors. The Reverse Stock Split is intended to help the Company regain compliance with Nasdaq’s
Upon effectiveness of the Reverse Stock Split, every twenty (20) shares of SkinHealth Systems Class A Common Stock issued and outstanding will automatically be combined into one (1) share of Class A Common Stock. Based on the number of shares outstanding as of October 7, 2026, the Reverse Stock Split is expected to reduce the number of outstanding shares of Class A Common Stock from approximately 130.3 million to approximately 6.5 million. The Reverse Stock Split will not change the total number of authorized shares of Class A Common Stock or the par value per share.
The Reverse Stock Split will affect all stockholders uniformly and will not alter any stockholder’s percentage ownership interest in the Company, except as a result of the treatment of fractional shares. No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive a fractional share will instead receive cash in lieu of such fractional share.
In addition, the conversion rate of the Company’s
Continental Stock Transfer & Trust Company (“Continental”) is acting as the transfer and exchange agent for the Reverse Stock Split. Stockholders who hold registered shares in book-entry form at Continental are not required to take any action to receive split-adjusted shares. Stockholders who hold shares through a broker, bank or other nominee will have their positions automatically adjusted and are not required to take any action. Stockholders holding share certificates will receive instructions from Continental regarding the exchange of shares.
Additional information regarding the Reverse Stock Split is available in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on August 12, 2026.
About SkinHealth Systems
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp™ with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
Forward-Looking Statements
All statements, other than statements of historical fact, included in this communication that address activities, events or developments that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements, as defined under U.S. federal securities laws.
Forward-looking statements can be identified by the use of words such as the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding the Reverse Stock Split, the expected effect on the per share trading price of Class A Common Stock, the Company’s ability to regain compliance with Nasdaq’s minimum bid price requirement for continued listing on The Nasdaq Capital Market, the expected number of post-split shares outstanding, and the treatment of fractional shares. These forward-looking statements are inherently uncertain and involve numerous assumptions and risks. Factors that could cause actual results to differ materially from those projected include, but are not limited to: (i) the Reverse Stock Split may not result in a sustained increase in the per share trading price of the Company’s Class A Common Stock; (ii) the Reverse Stock Split may decrease the trading liquidity of the Company’s Class A Common Stock; (iii) the Reverse Stock Split may not result in the Company regaining compliance with Nasdaq’s minimum bid price requirement; and (iv) other important factors detailed in the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other documents that are filed, or will be filed, with the U.S. Securities and Exchange Commission (the “SEC”) and that are or will be available on the Company’s website at www.skinhealthsystems.com and on the website of the SEC at www.sec.gov. Those risks continue to be relevant to the Company's performance and financial condition. Moreover, the Company operates in a very competitive and rapidly changing environment. New risk factors emerge from time-to-time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts:
Press: press@skinhealthsystems.com
Investors: IR@skinhealthsystems.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does SkinHealth Systems’ SKIN reverse stock split take effect, and what is the ratio?
The 1-for-20 reverse stock split takes effect at 12:00 a.m. ET on October 14, 2026. Every twenty outstanding Class A common shares will combine into one share. Split-adjusted trading on the Nasdaq Capital Market is expected at market open that day under SKIN.